Juan Carlos Izpisua Belmonte from the Salk Institute discussed aging and regenerative medicine at the KAUST 2019 Winter Enrichment Program. His team is combining gene editing and stem cell technologies to grow rat organs in mice and human cells in pig and cattle embryos. The Salk team is collaborating with KAUST to rejuvenate organs using noncoding RNAs and small metabolites. Why it matters: This research collaboration between KAUST and the Salk Institute explores innovative approaches to address age-related diseases and organ regeneration, with potential long-term impacts on healthcare in the region.
KAUST researchers, in collaboration with the Salk Institute and Altos Labs, have identified a class of RNA (LINE-1) that, when compromised, leads to accelerated aging, as seen in progeria. They devised an antisense RNA strategy to block the aberrant function of L1 RNA, reversing the disease in mice and patient-derived cells. Published in Science Translational Medicine, the research suggests that targeting LINE-1 RNA could treat progeroid syndromes and other age-related diseases. Why it matters: This RNA-based approach provides a potential therapeutic avenue for treating premature aging diseases and extending human health span in the region and globally.
MBZUAI Professor Fakherddine Karray is developing deep learning algorithms for human activity recognition to monitor the health and safety of elderly people. The AI tools analyze movement, posture, and facial expressions to detect early warning signs of health emergencies. Remote patient monitoring systems integrate smart devices and secure communication to allow elderly patients to stay at home and communicate with healthcare providers. Why it matters: AI-powered smart homes can provide affordable healthcare solutions for the rapidly growing elderly population in the region and worldwide.
American artist Rachel Sussman spoke at KAUST's 2019 Winter Enrichment Program about her project documenting the world's oldest living organisms. Sussman photographed 30 species alive for over 2,000 years, including trees, coral, and bacteria. She collaborated with 30 scientists to identify and document these organisms. Why it matters: The lecture highlights KAUST's interdisciplinary approach to knowledge, connecting art, science, and philosophy to explore concepts of time and longevity.
KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.
KAUST has launched the Center of Excellence for Smart Health (KCSH), chaired by Professor Imed Gallouzi and co-chaired by Professor Xin Gao. The center aims to develop smart-health technologies, integrating AI, machine learning, and other disciplines to address health challenges. KCSH will collaborate with partners across Saudi Arabia to focus on personalized diagnosis, treatment, and prevention of diseases. Why it matters: This initiative addresses the evolving healthcare needs of Saudi Arabia's aging population and high prevalence of genetic diseases, positioning the Kingdom as a leader in smart health solutions.
The provided content mentions KAUST (King Abdullah University of Science and Technology) and its association with King Abdullah bin Abdulaziz Al Saud. It also includes a copyright notice. Why it matters: This is a routine update reflecting KAUST's branding and legal information.
A KAUST team developed piRNAi, a gene-silencing tool in nematode worms using synthetic RNA sequences interacting with the piRNA pathway. They successfully silenced genes involved in sex determination and other functions, demonstrating multiplexed gene silencing. The gene silencing lasted for varying durations across generations, up to six generations. Why it matters: This expands the molecular toolkit for gene manipulation and offers potential therapeutic applications in humans, given the presence of the same gene-silencing pathway.